Observational analysis shows that medication adherence predicts relapse in schizophrenia, highlighting the need for targeted interventions.
Medication adherence alone showed inconsistent effects; its protective role was pronounced in schizophrenia and among patients with high psychological well-being. Relapse prevention should prioritize enhancing adherence in schizophrenia and integrating psychological well-being interventions. Tailoring management to diagnostic subgroups is essential for improving outcomes.
No takes yet. Share an insight, caveat, or question.
Nkubili et al. (2025) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: